Market Exclusive

Analyst Activity – Jefferies Group Initiates Coverage On NASDAQ:CRVS – Corvus Pharmaceuticals (NASDAQ:CRVS) With a Buy

Analyst Ratings For NASDAQ:CRVS – Corvus Pharmaceuticals (NASDAQ:CRVS)

Today, Jefferies Group initiated coverage on NASDAQ:CRVS – Corvus Pharmaceuticals (NASDAQ:CRVS) with a Buy with a price target of $17.00.

Some recent analyst ratings include

Recent Insider Trading Activity For NASDAQ:CRVS – Corvus Pharmaceuticals (NASDAQ:CRVS)
NASDAQ:CRVS – Corvus Pharmaceuticals (NASDAQ:CRVS) has insider ownership of 39.50% and institutional ownership of 86.61%.

Recent Trading Activity for NASDAQ:CRVS – Corvus Pharmaceuticals (NASDAQ:CRVS)
Shares of NASDAQ:CRVS – Corvus Pharmaceuticals closed the previous trading session at 12.08 up +0.52 4.54% with 12.09000015258789 shares trading hands.

Exit mobile version